Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0120 Transporter Info
Gene Name	SLC17A7
Transporter Name	Vesicular glutamate transporter 1
Gene ID	57030
UniProt ID	Q9P2U7

Post-Translational Modification of This DT
Overview of SLC17A7 Modification Sites with Functional and Structural Information
Sequence	M E F R Q E E F R K L A G R A L G K L H R L L E K R Q E G A E T L E L S A D G R P V T T Q T R D P P V V D C T C F G L P R R Y I I A I M S G L G F C I S F G I R C N L G V A I V S M V N N S T T H R G G H V V V Q K A Q F S W D P E T V G L I H G S F F W G Y I V T Q I P G G F I C Q K F A A N R V F G F A I V A T S T L N M L I P S A A R V H Y G C V I F V R I L Q G L V E G V T Y P A C H G I W S K W A P P L E R S R L A T T A F C G S Y A G A V V A M P L A G V L V Q Y S G W S S V F Y V Y G S F G I F W Y L F W L L V S Y E S P A L H P S I S E E E R K Y I E D A I G E S A K L M N P L T K F S T P W R R F F T S M P V Y A I I V A N F C R S W T F Y L L L I S Q P A Y F E E V F G F E I S K V G L V S A L P H L V M T I I V P I G G Q I A D F L R S R R I M S T T N V R K L M N C G G F G M E A T L L L V V G Y S H S K G V A I S F L V L A V G F S G F A I S G F N V N H L D I A P R Y A S I L M G I S N G V G T L S G M V C P I I V G A M T K H K T R E E W Q Y V F L I A S L V H Y G G V I F Y G V F A S G E K Q P W A E P E E M S E E K C G F V G H D Q L A G S D D S E M E D E A E P P G A P P A P P P S Y G A T H S T F Q P P R P P P P V R D Y
PTM type	X-Oxidation X-Phosphorylation X-S-nitrosylation X-Ubiquitination X: Amino Acid

Oxidation
Cystine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC17A7			[1]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	171
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC17A7 Cystine 171 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC17A7			[1]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	190
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC17A7 Cystine 190 has the potential to affect its expression or activity.
Phosphorylation
Serine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC17A7			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	36
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC17A7 Serine 36 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC17A7			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	94
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC17A7 Serine 94 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC17A7			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	281
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC17A7 Serine 281 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC17A7			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	292
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC17A7 Serine 292 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC17A7			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	301
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC17A7 Serine 301 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC17A7			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	372
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC17A7 Serine 372 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC17A7			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	504
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC17A7 Serine 504 has the potential to affect its expression or activity.
Threonine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC17A7			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	95
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC17A7 Threonine 95 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC17A7			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	289
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC17A7 Threonine 289 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC17A7			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	293
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC17A7 Threonine 293 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC17A7			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	300
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC17A7 Threonine 300 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC17A7			[5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	373
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC17A7 Threonine 373 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC17A7			[5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	374
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC17A7 Threonine 374 has the potential to affect its expression or activity.
Tyrosine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC17A7			[8]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	169
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC17A7 Tyrosine 169 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC17A7			[4]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	305
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC17A7 Tyrosine 305 has the potential to affect its expression or activity.
S-nitrosylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC17A7			[9]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	171
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at SLC17A7 Cystine 171 has the potential to affect its expression or activity.
Ubiquitination
Lysine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC17A7			[10] , [11]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	272
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC17A7 Lysine 272 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC17A7			[10] , [11]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	283
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC17A7 Lysine 283 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC17A7			[11]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	290
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC17A7 Lysine 290 has the potential to affect its expression or activity.

References
1	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
2	Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat Immunol. 2013 Nov;14(11):1166-72.
3	Synthesizing Signaling Pathways from Temporal Phosphoproteomic Data. Cell Rep. 2018 Sep 25;24(13):3607-3618.
4	An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
5	Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway. Mol Biosyst. 2013 Apr 5;9(4):732-49.
6	An orthogonal proteomic survey uncovers novel Zika virus host factors. Nature. 2018 Sep;561(7722):253-257.
7	MASTL overexpression promotes chromosome instability and metastasis in breast cancer. Oncogene. 2018 Aug;37(33):4518-4533.
8	Quantitative analysis of signaling networks across differentially embedded tumors highlights interpatient heterogeneity in human glioblastoma. J Proteome Res. 2014 Nov 7;13(11):4581-93.
9	MDD-SOH: exploiting maximal dependence decomposition to identify S-sulfenylation sites with substrate motifs. Bioinformatics. 2016 Jan 15;32(2):165-72.
10	Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
11	Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease. Proteomics. 2018 Oct;18(20):e1800108.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence